Login / Signup

Cold Agglutinin Disease and COVID-19: A Scoping Review of Treatments and Outcomes.

Jackson S MusuuzaSilpa KumarDheeraj Kumar PosaAakash HansSankett NayyarLeslie Ann ChristensenGilbert-Roy Kamoga
Published in: Journal of clinical medicine research (2024)
This review found no increased risk of severe outcomes in CAD and COVID-19 patients treated with rituximab.
Keyphrases
  • coronavirus disease
  • sars cov
  • diffuse large b cell lymphoma
  • early onset
  • adipose tissue
  • insulin resistance
  • glycemic control